Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer
Authors:
Top Cited Papers
Open Access
- 3 August 2023
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 41 (8) , 1516-1534.e9
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- Fundación Ramón Areces
- National Institutes of Health
- Yale Cancer Center (T32 CA193200-01A1)
- Howard Hughes Medical Institute
- Boehringer Ingelheim
- National Cancer Institute (P30 CA016359, U01CA235747)
This publication has 110 references indexed in Scilit:
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1Proceedings of the National Academy of Sciences, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb functionNature Cell Biology, 2011
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivoProceedings of the National Academy of Sciences, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell linesHuman Mutation, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005